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ABSTRACT: αRep is a family of entirely artificial repeat
proteins. Within the previously described αRep library, some
variants are homodimers displaying interdomain cavities.
Taking advantage of these properties, one of these
homodimers called αRep A3 was converted into entirely
artificial single chain bidomain metalloenzymes. A non-
mutated A3 domain was covalently linked with an A3′
domain bearing a unique cysteine on a chosen mutated
position (F119C or Y26C). This single mutation ensured the
covalent coupling of a 1:1 copper(II)/phenanthroline or
copper(II)/terpyridine complex as a catalytic center within the interdomain cavity which was maintained large enough to
accommodate two substrates of the Diels−Alder (D−A) reaction. This allowed us to obtain four new artificial Diels−Alderases
that were fully characterized by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, UV−vis
spectroscopy, and size exclusion chromatography analyses and were then further used for the catalysis of the D−A reaction.
They were found to be able to catalyze the enantioselective D−A reaction of azachalcone with cyclopentadiene with up to 38%
yield and 52% enantiomeric excess, which validates the proposed strategy. Moreover, the data were rationalized with a
computational strategy suggesting the key factors of the selectivity. These results suggest that artificial metalloenzymes based on
bidomain A3_A3 proteins modified with nitrogen donor ligands may be suitable for further catalyst optimization and may
constitute valuable tools toward more efficient and selective artificial biocatalysts.
■ INTRODUCTION
Artificial metalloenzymes have emerged as a powerful new
approach to expand the repertoire of chemical reactions
performed by enzymes.1 Engineering such new biohybrid
catalysts requires a stable host protein displaying a cavity wide
enough to accommodate a metal complex responsible for the
catalytic process and accessible for the substrates of the
catalyzed reaction. αRep are artificial proteins especially well
adapted to the development of a new class of hybrid catalysts.
These highly thermostable proteins based on an idealized α-
helical repeated motif2,3 are devoid of cysteine residues and
present a hypervariable surface that can be evolved to create
new protein−protein interactions.2,4 Recently, described αRep-
based biohybrid catalysts were designed using a homodimeric
αRep named αRep A3 as protein scaffold. These new artificial
Diels−Alderases were obtained by the covalent grafting of a
copper(II)−phenanthroline moiety into cysteine-mutated
αRep A3 variants. Positions 26 and 119 were mutated into
cysteine and then used for the covalent coupling of the
phenanthroline moiety. The choice of these two positions was
based on the crystal structure of αRep A3.3 For these two
positions, the side chains point into the inter-subunit crevice
quite deep in the crevice and these positions are among a set of
positions highly tolerant to side chain substitutions. In
addition, models of two resulting biohybrids, αRep
A3F119C-phenanthroline (A3-F119C-Phen) and αRep
A3Y26C-phenanthroline (A3-Y26C-Phen), suggested that the
dimer could accommodate two phenanthroline ligands in the
crevice. Finally, the distance between the two β-carbon atoms
of symmetrical Tyr26 residues was longer than the distance
between the two β-carbon atoms of symmetrical Phe119
residues, suggesting that the resulting biohybrids would
present different catalytic properties. The best resulting
biohybrid A3F119C-Phen−Cu(II) was found to be able to
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enantioselectively catalyze the Diels−Alder cycloaddition of
azachalcone with cyclopentadiene with up to 62% enantio-
meric excess (ee) but with only 11% yield. Such a low yield
could be explained by the presence, as the catalytic species, of
the 1:2 copper(II) bis-phenanthroline complex buried in the
crevice formed by the protein dimer, which could block the
access of the two substrates to the catalytic pocket.3 The
formation of such a species was due to the close proximity of
the two phenanthroline ligands covalently attached to the two
Cys119 residues facing each other in the symmetric dimer.
Then, this suggested developing a strategy to anchor only one
copper(II) complex as the catalytic center in the catalytic
pocket formed by the dimer’s interface. In addition, such an
approach should maintain a large catalytic pocket in order to
accommodate both D−A substrates and thus improve the
catalytic properties of the biohybrid catalysts. Such an
asymmetric biohybrid cannot be obtained from a homodimeric
protein and therefore needs to be created from one protein
scaffold containing two different domains linked together in
order to obtain an asymmetric bidomain protein. The metal
complex can then be grafted on a single cysteine located on
one of the two domains while the second domain contains no
cysteine residue. We recently described the construction of the
single chain bidomain protein A3_A3 in which two A3
domains were encoded by different genetic sequences and
linked by a flexible (SGGGG)2 peptide.
5
Herein, we report the successful production of single-chain
bidomain proteins in which a cysteine-free domain was linked
with a domain bearing either the F119C mutation [(A3_A3′)-
F119C] or the Y26C mutation [(A3_A3′)Y26C]. Further
chemical coupling of either a phenanthroline ligand (Phen) or
a bulkier terpyridine ligand (Terpy) followed by insertion of a
copper(II) ion led to four new artificial metalloenzymes
((A3_A3′)F119C-Phen−Cu(II), (A3_A3′)F119C-Terpy−
Cu(II), (A3_A3′)Y26C-Phen−Cu(II), and (A3_A3′)Y26C-
Terpy−Cu(II)) that were characterized by matrix-assisted laser
desorption ionization time-of-flight (MALDI-ToF) mass
spectrometry (MS) and size exclusion chromatography. This
new class of artificial metalloenzymes was found to be able to
catalyze the enantioselective Diels−Alder (D−A) reaction of
azachalcone with cyclopentadiene presenting up to 38% yield
and ee up to 52%, which validates the proposed strategy.
Molecular modeling allowed the identification of the
preferential orientations of the two copper complexes in the
binding pocket. The computation allowed suggesting the key
recognition factors of the stereo determining step of the
reaction.
■ RESULTS AND DISCUSSION
Engineering of the Host Protein. As the first αRep-
based biohybrid design was based on the αRep A3 homodimer,
the introduction of a single cysteine in the polypeptide chain
Figure 1. Successive steps for the preparation of biohybrids based on the (A3_A3′)F119C and (A3_A3′)Y26C variants functionalized with -Phen−
and -Terpy−Cu(II) complexes: (A) genetic constructions encoding the bidomain A3_A3′ proteins obtained by site-directed cysteine mutations
F119C or Y26C. The resulting plasmids were transformed in E. coli and the two proteins (A3_A3′)F119C and (A3_A3′)Y26C were produced and
purified. (B) Covalent ligand coupling of phenanthroline or terpyridine functionalized with a maleimide moiety followed by a Cu(II) metallation
step. (C) Models for the four resulting biohybrids based on the crystallographic structure of A3 homodimer (3LTM).
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resulted in the presence of two cysteine residues within the
dimer’s cavity and therefore necessarily ended up with a
symmetrical coupling of two chemical ligands. In order to
explore the effect of a single metal complex anchored in the
cavity of this protein, we needed to mutate one residue of only
one domain of the dimer into cysteine. The differentiation of
the two domains of the dimer can be achieved by mutation if
they were expressed as in a bidomain monomeric protein. We
recently described the genetic construction of a plasmid
encoding such an A3_A3 bidomain monomeric protein, in
which a synthetic nonrepeated gene encoded the first domain
and the repeated sequence contained in the αRep library
encoded the second domain. The two domains are covalently
linked on a single polypeptide chain by a flexible linker
sequence. The X-ray structure of this nonmutated bidomain
A3_A3 protein (PDB ID 6FT5) showed that the linker did not
affect the global structure of the monomer and functional
studies indicated that the linker reinforced the closed form of
the bidomain protein.5 Taking advantage of the nonrepeated
sequence of the first domain, mutations could selectively be
introduced in this domain. In order to compare the activities of
the resulting biohybrids with the previously described dimer’s
activities, the same positions as in the dimer were chosen for
cysteine mutation (F119 and Y26). The corresponding
synthetic genes obtained by site directed mutagenesis were
sub-cloned into a modified expression vector, which resulted in
plasmids encoding the two bidomain variants (A3_A3′)F119C
and (A3_A3′)Y26C. The proteins were produced in
Escherichia coli and purified as described and yields were
equivalent to the ones obtained with the dimers (between 50
and 70 mg of pure protein per liter of culture). Analytic size
exclusion chromatography profiles were equivalent to that of
the A3 dimer and to that of the nonmutated A3_A3 bidomain
protein, indicating that the mutations did not affect the global
protein conformation.
Bioconjugation. For this study, we selected two robust
copper(II) ligands with different nitrogen donor motifs that is,
phenanthroline and terpyridine, which are known to bind
copper(II) with strong affinities to give Cu(II) complexes and
that are able to catalyze D−A reactions.6,7 Derivatives of these
ligands had to be prepared to enable their covalent attachment
to the (A3_A3′)F119C and (A3_A3′)Y26C variants. 2-
Bromo-N-(1,10-phenanthrolin-5-yl)acetamide (1) and N-[2-
([2,2′:6′,2″-terpyridin]-4′-yloxy)ethyl]maleimide (3) were
prepared following already described procedures (see Exper-
imental Section) as they bear reactive bromoacetyl group and
maleimido group, respectively, which could react with the thiol
function of the cysteinyl residues of the mutant proteins
(Figure 1). The reactivity and accessibility of the thiol function
of the cysteinyl residues was then assessed, thanks to the time-
resolved Ellman’s assay using sulfhydryl reagent 5,5-dithio-bis-
(2-nitrobenzoic acid) (DTNB) that reacts with sulfhydryl
groups, releasing 2-nitro-5-thiobenzoate (TNB−) which dis-
plays a maximum absorption at 412 nm.8 First, for each one of
the two variants, the labeled cysteine concentration at the end
of the reaction was equal to the protein concentration. This
indicated that all cysteine residues were reactive and did not
form any disulfide bridge even after several weeks’ storage
without any reducing agent. Second, the kinetic of the reaction
was different for the two variants: (A3_A3′)Y26C showed very
fast labeling kinetics and led rapidly to a stable maximum
absorbance at 412 nm: (t1/2 = 30 s), while (A3_A3′)F119C
reacted more slowly with DTNB and the absorbance at 412
nm reached a plateau value only after several minutes: (t1/2 = 3
min 30 s).
This denoted in (A3_A3′)F119C either a sterically hindered
environment or a shift in the pKa of Cys119. Thus, the thiol
function appeared to be more accessible and more reactive in
(A3_A3′)Y26C than in (A3_A3′)F119C. It is noteworthy
that, in both cases, those t1/2 values were longer than those
measured for the symmetrical (A3Y26C)2 and (A3F119C)2
containing no linker (resp. 30 s vs instantaneous and 3 min 30
s vs 1 min 40 s).3 This indicated that in the single chain
(A3_A3′)Y26C and (A3_A3′)F119C proteins the linker
peptide stabilizes the closed form of the binding cavity. This
result is in accord with by the functional studies reported for
the nonmutated A3_A3, indicating that the interdomain
interactions are reinforced in the bidomain as compared to
the A3 homo-dimer.5
Protein Functionalization. The two variants
(A3_A3′)Y26C and (A3_A3′)F119C were then functionalized
by incubation with 1.2 equiv of 2-bromo-N-(1,10-phenan-
throlin-5-yl)acetamide hydrobromide or 2 equiv of N-[2-
([2,2:6,2-terpyridine]-4-yloxy)ethyl]maleimide overnight at 4
°C, resulting in the formation of the cysteine−phenanthroline
(Phen) or cysteine−terpyridine (Terpy) labeled proteins in
their apo form: (A3_A3′)Y26C-Phen, (A3_A3′)F119C-Phen,
(A3_A3′)Y26C-Terpy, and (A3_A3′)F119C-Terpy. The
complete functionalization was confirmed by Ellman’s assay,
with a complete loss of thiol reactivity (data not shown).
MALDI-ToF MS analysis was first used to characterize the
biohybrids (Figure 2). Peaks at 42 564 ± 5 and 42 706 ± 5 Da
Figure 2. MALDI-ToF spectra of the (A3_A3′)Y26C (A) and (A3_A3′)F119C (B) protein variants measured before (blue) and after
functionalization with terpyridine (red) and phenanthroline (green).
ACS Omega Article
DOI: 10.1021/acsomega.8b03448
ACS Omega 2019, 4, 4437−4447
4439
were observed respectively for (A3_A3′)Y26C-Phen and
(A3_A3′)Y26C-Terpy that were in agreement with the
covalent anchoring of one phenanthroline and one terpyridine
per protein (calculated mass 42 565 and 42 702 Da,
respectively) (Figure 2A). Peaks at 42 585 ± 5 and 42 720 ±
5 Da were also observed in the mass spectra of (A3_A3′)-
F119C-Phen and (A3_A3′)F119C-Terpy, respectively (Figure
2B), that were in agreement with the covalent anchoring of
one phenanthroline and one terpyridine ligand per protein
(calculated mass 42 581 and 42 718 Da, respectively).
When the functionalization experiment was performed on
the A3_A3 protein bearing no cysteine residues, the MALDI-
ToF MS analysis showed only a peak at 42 346 Da
corresponding to the noncoupled protein, which indicated
that the coupling reaction only occurred in the presence of
cysteine residues in the variants and that no other reactive
group was modified (data not shown).
Insertion of Copper(II) into the (A3_A3′)Y26C and
(A3_A3′)F119C Variants Functionalized with Phen and
-Terpy. The (A3_A3′)Y26C-Phen−Cu(II) and (A3_A3′)-
F119C-Phen−Cu(II) biohybrids did not present any charac-
teristic absorbance in the 300−400 nm range that could allow
us to follow the binding of the copper(II) ion to the ligand. On
the contrary, for (A3_A3′)Y26C-Terpy−Cu(II) and
(A3_A3′)F119C-Terpy−Cu(II) biohybrids, the insertion of
Cu(II) into the terpyridine ligand was accompanied by the
appearance of two bands at 320 and 330 nm assigned to the π
→ π * transition of the Terpy−Cu(II) complex (Figure 3). It
was therefore possible to carry out a titration of the
(A3_A3′)Y26C-Terpy and (A3_A3′)F119C-Terpy biohybrids
by increasing amounts of copper(II) nitrate by following the
absorbance at 320 nm as a function of the Cu(NO3)2/
(A3_A3′)Y26C-Terpy and (A3_A3′)F119C-Terpy ratio.
In a typical experiment, the effect of the successive additions
of 0.2 equiv of Cu(NO3)2, from 0 to 1.6 equiv, to a 5.6 μM
solution of (A3_A3′)Y26C-Terpy in 20 mM MOPS 150 mM
NaCl pH 7, was followed by UV−visible spectroscopy (Figure
3A). This allowed us to follow the gradual appearance of the
bands at 320 and 330 nm characteristic of the (A3_A3′)Y26C-
Terpy−Cu(II) complex and the formation of an isosbestic
point at 306 nm. When plotting the absorbance at 320 nm as a
function of the number of equiv of Cu(II) added to
(A3_A3′)Y26C-Terpy (Figure 3A, inset), a typical saturation
curve was obtained with a linear increase, till to 1 equiv of
Cu(NO3)2 added (red dots), of the absorbance at 320 nm
which then remains about constant for higher concentrations
of Cu(NO3)2 (blue dots). This is clearly the sign of the
formation, with a 1:1 stoichiometry, of a (A3_A3′)Y26C-
Terpy−Cu(II) complex in which the Terpy ligand displayed a
high affinity for the copper(II) ion. The same experiment was
performed with (A3_A3′)F119C-Terpy at a concentration of
13.5 μM and similar results were obtained (Figure 3B), the
isosbestic point being at 303 nm and the maximum absorbance
wavelength of the bands being 318 and 330 nm in this case.
Moreover, the calculation of molar extinction coefficient of the
complex at 318 nm resulted in a value of 6500 M−1·cm−1 for
(A3_A3′)Y26C-Terpy−Cu(II) and 9500 M−1·cm−1 for
(A3_A3′)F119C-Terpy−Cu(II). These shifts can be caused
by either the small differences between the spectral properties
of the two variants, or by a different environment of the
terpyridine moiety inside the (A3_A3′)Y26C and (A3_A3′)-
F119C pocket.
It is noteworthy that when the solution was subjected to
chromatography on a column of molecular sieves, which
removed the excess of copper nitrate, the A3sA3Y26Terpy−
Cu(II) complex was recovered unchanged, as shown by its
UV−visible spectrum. This confirmed the high affinity of
(A3_A3′)Y26C-Terpy for Cu(II). However, it was possible to
remove Cu(II) from the Terpy ligand by incubating the
purified complex with a large excess of ethylenediaminetetra-
acetic acid (EDTA) (5 mM).
Consequently, for further use as catalysts for the D−A
reaction, 100 μM solutions of (A3_A3′)F119C-Phen−Cu(II),
(A3_A3′)Y26C-Phen−Cu(II), (A3_A3′)F119C-Terpy−Cu-
(II), or (A3_A3′)Y26C-Terpy−Cu(II) in buffer A were
prepared by adding 1 equiv of copper nitrate (10 mM in
water) to the corresponding biohybrids solutions, as described
in the Experimental Section. The final solutions were
chromatographed on molecular sieves prior to use in order
to remove any excess of Cu(II) that could bind nonspecifically
to the protein.
Analytic Size−Exclusion Profiles of the Biohybrids. In
order to ensure that phenanthroline and terpyridine grafting on
the (A3_A3′)Y26C and (A3_A3′)F119C variants did not
disrupt the closed conformation of A3_A3 in solution, the
oligomeric states of the biohybrids copper complexes of
(A3_A3′)F119C-Phen, (A3_A3′)Y26C-Phen, (A3_A3′)-
Figure 3.Metallation of the (A3_A3′)Y26C-Terpy and (A3_A3′)F119C-Terpy biohybrids with Cu(II). (A) Evolution of the UV−visible spectrum
of (A3_A3′)Y26C-Terpy after the progressive addition of up to 1.6 equiv Cu(NO3)2 to a 5.6 μM solution of (A3_A3′)Y26C-Terpy in 20 mM
MOPS 150 mM NaCl pH 7 at 20 °C. Inset: evolution of the absorbance at 320 nm as a function of the number of equiv. of Cu(NO3)2/
(A3_A3′)Y26C-Terpy. (B) Evolution of the UV−visible spectrum of (A3_A3′)F119C-Terpy after the progressive addition of up to 1.6 equiv
Cu(NO3)2 to a 13.5 μM solution of (A3_A3′)Y26C-Terpy in 20 mM MOPS 150 mM NaCl pH 7 at 20 °C. Inset: evolution of the absorbance at
318 nm as a function of the number of equiv of Cu(NO3)2/(A3_A3′)F119C-Terpy.
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F119C-Terpy, and (A3_A3′)Y26C-Terpy were investigated by
gel filtration (Figure 4).
First, the elution volumes of the two variants (A3_A3′)-
F119C (10.84 mL) and (A3_A3′)Y26C (10.72 mL) were very
close to the elution volume of wild type A3_A3 (10.87 mL) in
the presence of Cu(II), indicating that the cysteine mutations
did not affect the monomeric structure and overall closed
conformation of the single chain bidomain protein. Then, the
elution volumes observed for the four biohybrids (10.70 mL)
for (A3_A3′)F119C-Phen−Cu(II), 10.77 mL for (A3_A3′)-
Y26C-Phen−Cu(II), 10.76 mL for (A3_A3′)F119C-Terpy−
Cu(II), and 10.78 mL for (A3_A3′)Y26C-Terpy−Cu(II)
remained very similar reflecting a very close hydrodynamic
radius value for all the proteins. This result showed that the
closed form of the A3_A3 protein was retained for the four
biohybrids and that the covalent attachment of both Terpy−
Cu(II) and Phen−Cu(II) complexes to the (A3_A3′)Y26C
and (A3_A3′)F119C variants did not alter the overall
conformation of the protein.
Catalysis of a Diels−Alder Reaction. The Diels−Alder
(D−A) cycloaddition is a very useful carbon−carbon bond-
forming reaction for the synthesis of organic building blocks,
and it has been widely studied.9,10 Very few enzymes are
known to catalyze this reaction,11 therefore artificial enzymes
with this activity present a high potential for synthetic
applications.12 As a consequence, in the last decade, many
artificial Diels−Alderases have been reported for the catalysis
of the benchmark reaction of azachalcone with cyclo-
pentadiene and showed variable endo/exo selectivities and
enantioselectivities.7,13−15
The reaction of 2-azachalcone (4) with cyclopentadiene (5)
(Scheme 1) was thus investigated in the presence of either the
unmodified A3_A3 protein or the (A3_A3′) cysteine mutant-
derived biohybrids, in the presence or not of copper(II)−
phenanthroline or −terpyridine complexes. It is noteworthy
that this reaction can result in up to four isomer products: two
major endo enantiomers (6a and 6b) and two minor exo
enantiomers (6c and 6d, Scheme 1). Consequently, in all the
cases, as the exo products were negligible versus endo
products, ee values were calculated for the endo products. In
all the cases where an enantiomeric excess was observed, the
major enantiomer was the 1S,2R,3R,4R endo product 6a with
respect to the 1R,2S,3S,4S endo product 6b as determined by
circular dichroism analysis.23
The D−A reactions were performed under the following
conditions: 34 mM 5 and 1 mM 4 were allowed to react in
buffer A, and no co-solvent added apart from the substrate
solution (1% acetonitrile) at 4 °C, in the presence of 30 μM of
catalyst (Table 1).
Under these conditions, in the absence of copper(II) nitrate,
very low yields were obtained, endo products 6a−b being
Figure 4. Size-exclusion profiles of the biohybrids. Solutions
containing sample proteins were injected on Superdex 75 10/300
GL column equilibrated in buffer A and elution profiles were recorded
using the absorbance at 280 nm. For all the samples, an excess of
copper(II) per protein monomer was pre-incubated before injection
on the column. Normalized elution profiles are shown for A3_A3
(black), (A3_A3′)F119C (red), (A3_A3′)Y26C (blue), and the
corresponding biohybrids (A3_A3′)F119C-Phen−Cu(II) (red,
dashed line), (A3_A3′)F119C-Terpy−Cu(II) (red, dotted line),
(A3_A3′)Y26C-Phen−Cu(II) (blue, dashed line) and (A3_A3′)-
Y26C-Terpy−Cu(II) (blue, dotted line).
Scheme 1. Diels−Alder (D−A) Reaction
Table 1. Compared ee, Yields, and Endo/Exo Ratio
Measured after the D−A Reaction of Cyclopentadiene 5
with 2-Azachalcone 4 in MOPS Buffer Catalyzed by Either
A3_A3, (A3_A3′)Y26C-Phen, (A3_A3′)Y26C-Terpy,
(A3_A3′)F119C-Phen, or (A3_A3′)F119C-Terpy
Biohybrids in the Presence of Copper(II)nitratea
catalyst ee (%) yield (%)
Cu(NO3)2 0 ± 1 38 ± 2
A3_A3 15 ± 3 7 ± 1
A3_A3 + Cu 3 ± 2 22 ± 3
A3_A3 + Phen−Cu 31 ± 1 9 ± 1
A3_A3 + Terpy−Cu 19 ± 1 7 ± 1
(A3_A3′)Y26C-Phen 12 ± 1 8 ± 2
(A3_A3′)Y26C-Terpy 16 ± 1 9 ± 2
(A3_A3′)F119C-Phen NDb 4 ± 1
(A3_A3′)F119C-Terpy 16 ± 1 6 ± 1
(A3_A3′)Y26C-Phen−Cu 22 ± 1 21 ± 2
(A3_A3′)Y26C-Terpy−Cu 14 ± 1 16 ± 2
(A3_A3′)F119C-Phen−Cu 5 ± 1 38±2
(A3_A3′)F119C-Terpy−Cu 52 ± 1 15 ± 1
aIn all experiments, 30 μM monomer protein was used after
incubation with 1 equiv of copper(II)nitrate. bee value could not be
determined in this case due to the low yield.
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obtained in about 7 ± 1% yield, even in the presence of A3_A3
with an enantiomeric excess of 15 ± 3% (Table 1). Copper(II)
nitrate alone was found to be able to catalyze the D−A
reaction, a 38 ± 2% yield in products 6 being obtained in the
presence of 30 μM Cu(NO3)2, but no enantiomeric excess was
observed. When both A3_A3 and copper(II) nitrate were
associated, a 22 ± 1% yield was obtained, but with a negligible
enantiomeric excess of about 3 ± 2%. When Phen−Cu and
Terpy−Cu were noncovalently inserted into A3_A3, to
generate the (A3_A3)-Phen−Cu and (A3_A3)-Terpy−Cu
biohybrids following the “host−guest” strategy, low yields in
endo products were formed (resp. 7 and 9 ± 1%) but higher ee
of respectively 31 ± 1 and 19 ± 1% were measured.
When the reactions were run in the presence of either the
four biohybrids, (A3_A3′)Y26C-Phen or -Terpy, and
(A3_A3′)F119C-Phen or -Terpy, but in the absence of
copper(II), rather low yields ranging from 6 ± 1 to 9 ± 1%
were obtained.
When the (A3_A3′)Y26C derived biohybrids were used in
the presence of copper(II), quite similar results were observed,
(A3_A3′)Y26C-Phen−Cu leading both to slightly higher yield
(21 ± 2%) and enantiomeric excess (22 ± 1%) than
(A3_A3′)Y26C-Terpy−Cu (16 ± 2% yield and 14 ± 1% ee).
When the reactions were catalyzed by (A3_A3′)F119C
derived biohybrids, two different results were observed. First,
when (A3_A3′)F119C-Phen−Cu(II) was used as catalyst, a
higher yield in product 6 (38 ± 2%) was obtained but almost
no enantiomeric excess was detected (5 ± 1%). On the
contrary, when the Phen ligand was replaced by the more
bulky ligand terpyridine (A3_A3′)F119C-Terpy−Cu(II), the
enantiomeric excess increased to reach 52 ± 1% but the yield
in product 6 decreased to 15 ± 1%.
Molecular Modeling. A computational approach was
subsequently performed to rationalize these data. Our strategy
consisted in (i) building the two models of the biohybrid
variants (A3_A3′)Y26C and (A3_A3′)F119C; (ii) character-
izing throughout density functional theory (DFT) calculations
on cluster models the geometries of intermediates and
products along the copper mediated D−A reaction; and (iii)
inserting those geometries into the variant models by
optimized protein−ligand docking. The complementarity of
the catalytically relevant structures into the context of the
catalysis was then discussed. More concretely, the modeling
consisted in building the biohybrid structures of the metal free
cofactors covalently linked to (A3_A3′)Y26C and (A3_A3′)-
F119C following the three different reaction steps: (1) the
resting state of the artificial metalloenzymes produced by
metalation of the hybrids (docking of Cu(cofactor)(H2O)2),
(2) ligand exchange leading to the formation of the co-
substrate-bound cofactor [docking of Cu(cofactor)(4)], and
(3) metal containing cofactor bound to endo-6a, -6b and exo-
6c, -6d D−A products to model the final step of the reaction
[docking of Cu(cofactor)(6)]. Because transition states full
characterization are not achievable by docking methods, and
accurate QM/MM calculations are out of the scope of the
present paper, simulation with product-like geometry were
expected to provide the main information concerning protein−
ligand recognition factors that could define the stereospecificity
of the biohybrid enzymes.24 Details on the results and their
analysis are reported in the Supporting Information.
When comparing the docking on the different structural
models of the reaction taking place with the biohybrids,
interesting structural tendencies appear. The calculations on
metal-free Phen and Terpy biohybrids show substantial
cofactor flexibility in the low energy solutions with the
cofactor being able to go from subpockets to different ones for
(A3_A3′) F119C-Phen and for (A3_A3′)F119C-Terpy. The
cofactor goes from the subpockets involving residues S147,
W143, D186, Q146, Y211′, W235′, D242′, Q246′ and W143,
Q146, S147, Y26′, G29′, K30′, W50′, A54′, A58′, Q61′, Q246′
to subpockets involving residues A116, I115, F112, Q34, A116,
V88 and W81, W143, W81′, Q84′, V88′, S85′, R53′, D57′,
W111′, F112′, I115′, for (A3_A3′)F119C-Phen and
(A3_A3′)F119C-Terpy, respectively. This scattering is though
largely reduced upon the loading of the metal and its aquo
ligands leading to low energy solutions with the cofactors and
Cu(II) directed toward the center of the hydrophobic binding
pocket (Table S1C). The major interactions for the lower
energy solutions are between the water molecules and side
chains of S85′, D57′, R53′, and R238′ as well as hydrophilic
contacts of the cofactor with W143, Q146, W50′, Y26′ , and
W143, Q146, W235′, Q246′, V273′ for (A3_A3′)F119C-
Phen−(H2O)2 and (A3_A3′)F119C-Terpy−(H2O)2, respec-
tively (see Supporting Information). These low energy
orientations are consistent with those obtained when the 2-
azachalcone substrate binds to the copper showing that the
metalated biohybrids present a good pre-organization of the
binding site for the first co-substrate. Finally, docking
simulations with the D-A products endo-6a, -6b, exo-6c, and
-6d all show good complementarities with the binding site
(more than 50.0 GoldScore units) though at this state we can
already observe that endo-6a products have better comple-
mentarity values than endo-6b with at least 5.2 GoldScore
fitness units (Table S2C).
In order to better understand the key recognition factors
involved in the enantiomeric selectivity, the dockings for the
Table 2. Selected GoldScore Values for the Docking of Metal Free Cofactor, Metalated Cofactor + Substrate, and Metalated
Cofactor + Endo-6a and 6b Productsa
(A3_A3′) variant isomer products yieldexp Fmax Fmax (Cu + 4) eeexp (%) Fmax (Cu + 6) ΔFmax
F119C-Phen 6a 38 ± 2 26.6 (9/50, I) 30.0 (45/50, II) 5 55.1 3.8
6b 51.3
Y26C-Phen 6a 21 ± 1 26.6 (6/50, IV) 29.8 (46/50, I) 22 33.6 5.6
6b 28.0
F119C-Terpy 6a 15 ± 1 40.3 (33/50, III) 42.0 (23/50, I) 52 61.7 7.2
6b 54.5
Y26C-Terpy 6a 16 ± 2 41.0 (21/50, II) 37.9 (1/50, IIX) 14 54.1 5.2
6b 48.9
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(A3_A3′)F119C-Phen−Cu-6a and 6b (5% ee) and (A3_A3′)-
F119C-Terpy−Cu-6a and 6b (52% ee) systems were repeated
considering the flexibility in solution of the side chains in the
binding pocket. All the data taken together could be
rationalized considering the steric hindrance of the binding
sites and the stabilization of the products with a transition
state-like geometry (Table 2).
In the case of (A3_A3′)F119C-Phen−Cu-(2-azachalcone),
it appeared that the Phen ligand and the substrate were
surrounded by a wide pocket showing van der Waals contacts
with V88, W143, Q84′, W99′, F112′, I115′, and W143′
(Figure 5a). The relatively open pocket and the limited
number of interacting residues could lead to a moderate
control of the relative positioning of both complex and
substrates, in fact, for (A3_A3′)F119C-Phen−Cu(endo-6),
both isomers reach binding modes with similar scoring (ΔFmax
= 3.8, Table 2). These considerations could explain both the
low ee observed as well as the higher yield in product 6 (38 ±
2%). On the contrary, in the case of (A3_A3′)F119C-Terpy−
Cu(2-azachalcone), the bulkier maleimide linker and Terpy
ligand lead to stronger van der Waals stabilizations of the
complex with R53, Q84, S85, V87, W81, F112, I115, W143,
W81′, Q84′, V88′, F112′, I115′, and W143′ that hinder its
flexibility and the access of the cyclopentadiene to one side of
the pocket (Figure 5c). Moreover, the docking analysis of
(A3_A3′)F119C-Terpy−Cu(endo-6a/6b) shows an equiva-
lent position of the terpyridine implying the specular
orientation of the two products that leads to favor the 6a
enantiomer stabilization, in particular the interactions of the
substrates with Q84, F112, I115, A116, W143, Q84′, V88′,
F112′, I115′, F119′, and W143′ (ΔFmax = 7.2, Figures 5d and
S2C). These two observations could explain both the increase
in the enantiomeric excess (5−52%) and the decrease in the
yield (38−15%).
Concerning the (A3_A3′)Y26C variant, the docking analysis
shows a significant stabilization of the intermediate Cu-
(cofactor)(2-azachalcone) with residues Q61, Q84, V88, A116,
I115, F119, W81′, Q83′, I115′, W143′, S148′ and Q84, V88,
F112, A116, W111, I115, F119, W143, Q85′, V88′, I115′,
A116′, F119′ for (A3_A3′)Y26C-Phen−Cu(4) and (A3_A3′)-
Y26C-Terpy−Cu(4), respectively. The preferential formation
of the 6a enantiomer is predicted obtaining fitness differences
of 5.6 and 5.2 GoldScore units for Phen and Terpy variants,
respectively. In analogy with the previous case, the (A3_A3′)-
Y26C-Terpy−Cu(2-azachalcone) shows both a larger pocket
and a higher variability in docking solutions. Accordingly, a
yield in product 6 of 16 ± 2% and an ee of 14 ± 1% were
found for (A3_A3′)Y26C-Phen−Cu(II) and a 21 ± 2% yield
in product 6 for (A3_A3′)Y26C-Phen−Cu(II) with an ee of
22 ± 1%. Both species are stabilized by van der Waals contacts
with V88, Q84, Q61, V88′, I115′, F119′, W143′, S147′, D150′
for (A3_A3′)Y26C-Phen−Cu(6a) and V88, Q84, W81, F119,
W143, W81′, Q84′, V88′, A116′, F119′, W143′ for (A3_A3′)-
Y26C-Terpy−Cu(6a) (Figure S1C).
Taken all together, the computation results suggest possible
further improvements to our system by, for example, stabilizing
the intermediates with bulkier hydrophobic residues in their
direct vicinity or hider the reactants access to one side of the
binding pocket favoring the selective formation of one
enantiomer. It is noteworthy that no significant effect of the
Figure 5. Representation of best docking solutions for the reactants
(A3_A3′)F119C-Phen−Cu(4), (A3_A3′)F119C-Phen−Cu(6) and
(A3_A3′)F119C-Terpy−Cu(4), (A3_A3′)F119C-Terpy−Cu(6) unit
showing their environment. The linker is depicted in green and the
side chains that change their conformation during binding are
highlighted in pink.
Table 3. Compared Yields and ee Measured after the D−A Reaction of Cyclopentadiene 5 with 2-Azachalcone 4 in the
Presence of Various Copper(II)-Biohybrid Catalysts Reported in the Literature
biohybrid catalyst protein−liganda conversion/yield (%) endo/exo (%) ee (%) refs
LmrR_M89C-Phenb 93 95:5 97 7
SB-Lys-GTL*/196-Phenb 98 93:7 25 17
HSA-phtalocyanin 89 91:9 85 18
NCS-Phenb 84 84:16 0 10,16
FhuA-NHCc 62 90:10 ND 19
FhuA-Tpyd 15 66:34 ND 10
A2A-Phen
d 28 82:18 19 14
NB-Tpyd 22 90:10 ND 6
A3F119C-Phenb (A3F119NPH) 11 86:14 62 3
(A3_A3′)F119C-Terpy 15 93/7 52 this work
(A3_A3′)F119C-Phen 38 92/8 5
aNomenclature for the various proteins used: LmrR, Lactococcal multidrug resistance regulator; SB-Lys-GTL*/196, Sepabeads Lys196 mutant of
Geobacillus thermocatenulatus lipase; HSA, human serum albumin; A3, αRep A3 protein; SCP-2L, sterol carrier protein type 2-like domain; NCS,
neocarzinostatin; NB, nitrobindin; FhuA, ferric hydroxamate uptake protein component A. A2A, A2 adenosine receptor.
bPhen, phenanthroline.
cNHC, N-heterocyclic carbene. dTpy, terpyridine.
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catalysis on regioselectivity was observed with either of the two
catalytic Cu(II) complexes in the A3_A3′ mutants as in all the
cases the endo/exo ratios were similar (92 ± 1:8 ± 1).
■ DISCUSSION
The characteristics of the D−A reaction catalyzed by
(A3_A3′)F119C-Terpy− and -Phen−Cu(II), yield, endo/exo
ratio, and enantiomeric excess, ee, are compared in Table 3
with those reported to date for the D−A reaction between 4
and 5 catalyzed by various artificial metalloenzymes.
Considering the endo/exo ratio, (A3_A3′)F119C-Terpy−
Cu(II) and (A3_A3′)F119C-Phen−Cu(II) (endo/exo = 93/7
and 92/8 resp.) stand among the systems that follow the
traditional endo rule with LmrR_M89C-Phen−Cu,7 SB-Lys-
GTL*/196-Phen−Cu17 (endo/exo = 95/5 and 93/7,
respectively), whereas FhuA-Tpy favored the formation of
the exo products (endo/exo = 66/34).10 Concerning the yields
in product 6, the best one that was obtained in this work, 38%
with (A3_A3′)F119C-Phen−Cu, was lower than those
obtained with the most efficient systems LmrR_M89C-
Phen−Cu,7 SB-Lys-GTL*/196-Phen−Cu,17 and HSA-phtalo-
cyanin−Cu18 that ranged between 89 and 98%, but were
higher than those reported for NB-Tpy-Cu6 and FhuA-Tpy-
Cu19 (22 and 15%, respectively). Finally, the best ee obtained,
52% with (A3_A3′)F119C-Terpy−Cu, was also lower than
those reported with LmrR_M89C-Phen (ee = 97%)7 and
HSA-phtalocyanin (ee = 85%)18 but higher than that reported
with SB-Lys-GTL*/196-Phen (ee = 25%).17 We recently
published the production of a NCS−phenanthroline−Cu(II)
artificial metalloenzyme, by the non-covalent insertion of a
testosterone−phenanthroline−Cu(II) conjugate into the bind-
ing site of NCS following the “Trojan Horse” strategy.16 This
biohybrid was found able to catalyze the D−A reaction with a
very good yield, 84%, but with no enantiomeric excess, which
could be explained both by the wide binding site of NCS open
to the solvent, with no control of the relative positioning of the
two D−A substrates, and the high flexibility of the catalytic
Phen−Cu(II) moiety due to its noncovalent anchoring to the
protein. We then reported a new artificial Diels−Alderase
A3F119NPH-Cu(II) that was obtained by covalent anchoring
of a copper(II)−phenanthroline moiety into the F119C
mutant of an artificial protein dimer based on a thermostable
α-helical repeated motif.3 In this case, a good enantioselectivity
(62% ee) was obtained but with the yield in product 6 was low
(11%), which could be explained by the presence of a
copper(II)bisphenanthroline complex, due to the close
proximity of the two phenanthroline ligands covalently
attached to the two Cys119 residues facing each other in the
symmetrical dimer, which blocked the access of the two
substrates to the catalytic center.3 Consequently, in order to
avoid this major drawback, we proposed to associate in a single
chain protein a single cysteine mutated A3 domain with
another nonmutated A3 domain, in order to ensure to have a
1:1 copper(II)−phenanthroline complex as catalytic center
and to enlarge the catalytic pocket in order to accommodate
both D−A substrates. The results presented in this paper show
that this strategy was successful for the production of four of
such new artificial metalloenzymes, (A3_A3′)Y26C and
(A3_A3′)F119C derived with Phen−Cu(II) and -Terpy−
Cu(II), that were obtained by the covalent anchoring of either
a copper(II)−phenanthroline cofactor or a copper(II)−
terpyridine cofactor to either a F119C mutant or a Y26C
mutant of the single chain A3_A3 protein. The strategy was
also successful to increase the yield of the reaction because
with (A3_A3′)F119C-Phen−Cu(II) as catalyst a 38 ± 2%
yield could be obtained, but unfortunately in this case a very
weak ee was found (5 ± 1%) as a result of both a bad control
of the relative positioning of the two substrates in the wide
pocket surrounding the Phen−Cu(II) cofactor and a too high
flexibility of this cofactor. A better ee could be obtained with
(A3_A3′)F119C-Terpy−Cu(II) (52 ± 1%), but this time a
low yield was found (15 ± 1%) resulting both from a lower
flexibility of the bulky Terpy−Cu(II) cofactor and from a
smaller sized pocket surrounding it, allowing a better control of
the relative positioning of the two substrates. These results
together with those reported earlier3 put in light that a good
compromise between flexibility of the cofactor and size of the
pocket surrounding it remain to be found to improve both the
yield and the enantioselectivity of the reaction. Another
important factor that has probably to be taken into account is
the accessibility of the substrates to the catalytic pocket, as
until now the A3 and A3_A3-derived biohybrids generally lead
to much lower yields than some reported in the litera-
ture.7,16−18 Indeed, the conformational study and ligand
binding study of A3_A3 shed light on the very tightly
stabilized closed conformation in the bidomain single chain
protein.5 Our results demonstrated that artificial metal-
loenzymes based on the A3_A3 protein modified with nitrogen
donor ligands may be suitable for further catalyst optimization
and constitute valuable tools toward more efficient and
selective artificial biocatalysts (Table 3).
■ EXPERIMENTAL SECTION
Plasmid Construction. The genetic sequence coding for
the protein αRep A3 was issued from a combinatorial library of
concatenated, repeated, and degenerated sequences. In order
to mutate the first domain only, repetitions in nucleotide
sequences were minimized to simplify site-directed muta-
genesis. The sequence was therefore recoded using different
codons for the same amino acid in consecutive repeats. The
new nucleotide sequence was designed using the GenScript
algorithm dedicated to codon optimization for E. coli
expression as previously described.3 The bidomain genetic
construction was recently described.5 Briefly, the synthetic
gene of A3 was cloned by CPEC into pQE81 plasmid
containing the original repeated sequence of A3 gene (named
A3′ in the mutated bidomain construction). The two genes
were separated by a linker sequence coding for repeated serine
and glycine residues (SGGGGSGGGG). The gene also
included a tobacco etch virus (TEV) protease cleavage site
after the N-terminal hexahistidine tag. The final construct then
encoded HisTag-TEVsite-A3-(SG4)2-A3′.
Directed Mutagenesis. Genes coding for the variants
(A3_A3′)F119C and (A3_A3′)Y26C were obtained by site-
directed mutagenesis using the QuikChange protocol with the
following primers (F119C-FOR: 5′-CGGCGGCGtgcGCAT-
TAGG; F119C-REV: 5′-CCTAATGCgcaCGCCGCCG;
Y41C-FOR: 5′-GCAGCGGCAtgcGCGCTGGG; and Y41C-
REV: 5′-CCCAGCGCgcaTGCCGCTG). The vector contain-
ing the A3_A3′ gene was amplified by PCR with Phusion high-
fidelity DNA polymerase (Thermo Scientific) as follows: initial
denaturation at 98 °C for 1 min; 20 cycles including a
denaturation step at 98 °C for 20 s, an annealing step at 65 °C
for 15 s, and an extension step at 72 °C for 3 min. The final
extension step was done at 72 °C for 10 min. The PCR
product was treated with Dpn I and directly used for
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transformation in E. coli XL1-Blue electrocompetent cells. For
each mutagenesis, plasmids from five independent clones were
purified using Nucleospin Plasmid extraction kit (Macherey
Nagel). The sequences of the variants were confirmed by
sequencing both DNA strands.
Protein Production. Chemocompetent E. coli M15
(Qiagen) bacteria were transformed with the desired plasmid
and grown on 2YT-agar plates supplemented with ampicillin
(100 μg/mL), kanamycin (50 μg/mL), and 1% glucose. One
clone was picked and grown overnight at 37 °C in liquid 2YT
medium supplemented with ampicillin (100 μg/mL) and
kanamycin (50 μg/mL). The overnight preculture was used to
inoculate 1 L of fresh medium distributed into two 2 L flasks.
Cells were grown at 37 °C until OD600nm reached 0.8, protein
expression was induced by the addition of 500 μM IPTG and
cultures were further incubated at 37 °C for 4 h. Cells were
harvested by centrifugation for 20 min at 5000g at 4 °C and
resuspended into 40 mL of washing buffer (50 mM sodium
phosphate pH 8; 300 mM NaCl; 20 mM imidazole).
Suspended cells were stored at −80 °C.
Protein Purification. Frozen cells from 1 L of bacterial
culture were thawed and a tablet of EDTA-free anti-protease
cocktail (Roche) was added. Cells were lysed by three 30 s
cycles of sonication on ice and centrifuged 30 min at 11 000g
at 4 °C. His-tagged proteins were purified from the crude
supernatant using nickel-affinity chromatography on a 4 mL
Ni−NTA column (Macherey Nagel). The column was washed
with 150 mL of washing buffer (50 mM sodium phosphate pH
8; 300 mM NaCl, 20 mM imidazole) and proteins were eluted
in six 1 mL fractions in the elution buffer (50 mM sodium
phosphate pH 8; 300 mM NaCl, 300 mM imidazole). A typical
yield of about 100 mg of protein per liter of culture was
obtained. Eluted fractions were analyzed by SDS-PAGE and
pure fractions of proteins were pooled, diluted five times with
50 mM sodium phosphate buffer pH 8, 150 mM NaCl, and
finally cleaved with His-tagged TEV protease obtained from
the pRK793 vector (Addgene): purified His-tagged TEV
protease and purified αRep bidomain protein with its cleavable
His-Tag were mixed in a 1:100 ratio in a total volume of 50 mL
and incubated overnight at 10 °C after the addition of 0.5 mM
EDTA and 1 mM DTT. The mixture was then diluted twice
with 50 mM sodium phosphate buffer pH 8, 150 mM NaCl
leading to a final 30 mM imidazole concentration and loaded
on another 4 mL Ni−NTA column equilibrated with the
washing buffer. His-tagged TEV protease and uncleaved His-
tagged αRep were retained on the column, while the flow
through containing cleaved αRep protein was recovered, and
concentrated resulting in a 5 mL solution that was loaded on a
gel filtration column (HiLoad 16/600 Superdex 75, GE
Healthcare) equilibrated with filtered coupling buffer (50
mM sodium phosphate pH 7.75, 150 mM NaCl). The
coupling buffer was previously incubated for 1 h with Chelex
100 resin (Bio-Rad). Elution fractions after gel filtration were
pooled and stored at 4 °C until chemical coupling. Purity was
checked by SDS-PAGE and concentrations were obtained
from the absorbance at 280 nm measured on a Nanodrop
spectrophotometer (Thermo Scientific) using extinction
coefficients at 280 nm calculated from the protein sequence
(https://web.expasy.org/protparam/) (58 900 M−1·cm−1 for
A3_A3, 58 900 M−1·cm−1 for (A3_A3′)F119C and 57 410
M−1·cm−1 for (A3_A3′)Y26C). After the cleavage step, a
typical yield of 40 mg of pure protein ready for the coupling
reaction was obtained.
Monitoring of Thiols Accessibility. The accessibility of
thiol groups of Cys119 and Cys26 in both variants was
monitored using Ellman’s test.20 In a standard assay, 445 μL of
reaction buffer (0.1 M sodium phosphate pH 8.0, 1 mM
EDTA) was mixed with 5 μL of reagent solution [10 mM 5,5′-
dithio-bis-(2-nitrobenzoic acid)] in a quartz cuvette. Absorb-
ance at 412 nm was monitored using a JASCO spectropho-
tometer. Absorbance was recorded in the kinetic mode after
the addition of 50 μL of a 100 μM protein solution until
complete reaction. The final absorbance obtained at the
plateau was noted Aeq and the initial absorbance measured
before protein addition was noted A0. The reduced cysteine
content was then calculated from the difference signal
corrected by the dilution factor using an εM value of 14 150
M−1·cm−1 at 412 nm.
Ligand Synthesis. Synthesis of 2-Bromo-N-(1,10-phe-
nanthrolin-5-yl)acetamide Hydrobromide (1). Compound
(1) Was Synthetized According to Literature.7 1,10-
phenanthrolin-5-amine (195 mg, 1 mmol) was solubilized in
a 50 mL two-necked round-bottom flask filled with 30 mL of
anhydrous CH2Cl2 and equipped with magnetic stirring and a
condenser. Bromoacetyl bromide (104 μL, 1.2 mmol) was
diluted in 10 mL anhydrous CH2Cl2 and added dropwise to
the phenanthroline solution. The mixture was then refluxed
overnight and the resulting suspension was filtered. Recrystal-
lization was performed in MeOH, leading to the HBr salt of
compound (1) as brownish crystals (yield 70%). 1H NMR
(300 MHz, DMSO-d6): δ 10.86 (s, 1H), 9.32 (dd, J = 4.5, 1.2,
1H), 9.21 (dd, J = 5, 1.2, 1H), 9.09 (d, J = 8.5, 1H), 9 (d, J =
8.5, 1H), 8.54 (s, 1H), 8.20 (t, J = 4.3, 1H), 8.17 (t, J = 4.3,
1H), 4.34 (s, 2H) ppm.
Synthesis of 2-(2,2′:6′,2″-Terpyridine-4′-yloxy) Ethyl-
amine (2). Compound (2) Was Synthetized According to
Literature.21 4′-Chloro-2,2′:6′,2″-terpyridine (159.7 mg) and
ethanolamine (60 μL) were stirred in a suspension of
powdered KOH (100 mg) in DMSO (2 mL) at 40 °C for 2
h. The reaction mixture was then added to 10 mL of CH2Cl2
and washed three times with water. The CH2Cl2 solution was
dried over MgSO4 and solvents evaporated. 2-(2,2′:6′,2″-
Terpyridine-4′-yloxy) ethylamine (145 mg) was obtained as a
light-yellow solid in 83% yield and used subsequently without
further purification. 1H NMR (360 MHz, CDCl3): δ 3.17 (t, J
= 5.11 Hz, 2H), 4.27 (t, J = 5.11 Hz, 2H), 7.33 (dd, J1 = 4.77
Hz, J2 = 0.92 Hz, 2H), 7.86 (td, J1 = 11.67 Hz, J2 = 2 Hz, 2H,
H4,4″), 8.03 (s, 2H), 8.61 (d, J = 7.96 Hz, 2H), 8.69 (d, J = 3.85
Hz, 2H) ppm. ESI-MS m/z: 293.13 (M), 315.12 (M + Na+).
Synthesis of N-[2-([2,2:6′,2″-Terpyridin]-4-yloxy)ethyl]-
maleimide (3). 2-([2,2′:6′,2″-Terpyridin]-4′-yloxy)ethylamine
(2) (136.4 mg) in 5 mL of acetone/water (2/1) was added
dropwise to a solution of NaHCO3 (118 mg) and N-
methoxycarbonylmaleimide (127 mg) in 5 mL of acetone/
water: 2/1 at 4 °C, and the reaction mixture was stirred for 1 h
30 min. The solution was added to water (3 mL) and stirred
for 2 h 30 min at room temperature. The obtained precipitate
was collected and washed with water. Yield: 158.2 mg (80%);
1H NMR (360 MHz, CDCl3): δ 8.68 (d, J = 4.83 Hz, 2H),
8.60 (d, J = 8.10 Hz, 2H), 7.98 (s, 2H), 7.84 (td, J = 7.72, 1.88
Hz, 2H), 7.34 (dd, J = 4.82, 1.22 Hz, 2H), 6.75 (s, 2H), 4.40
(t, J = 5.57 Hz, 2H), 4.03 (t, J = 5.55 Hz, 2H) ppm. ESI-MS
m/z: = 373.13 (M), 395.11 (M + Na+).
Ligands Coupling. In both protein variants, the
concentration of thiol groups obtained via Ellman’s test was
used as the cysteine concentration and thus of protein,
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available for either phenanthroline or terpyridine coupling.
Then, 1.2 equiv of compound 1, or 2 equiv of compound 3
were diluted in DMSO and mixed with 100 μM protein
solution in coupling buffer (50 mM Na-phosphate pH 7.75,
150 mM NaCl) for a final DMSO concentration of 1% in the
desired volume. The mixture was incubated at 4 °C overnight.
The coupling reaction was then stopped by the addition of 0.5
mM EDTA and 1 mM DTT. The protein solution was
concentrated to about 5 mL using a Vivaspin concentrator and
loaded on a gel filtration column (HiLoad 16/600 Superdex
75, GE Healthcare) equilibrated in buffer A (20 mM MOPS
150 mM NaCl, pH7) previously incubated with Chelex 100
resin and filtered. The coupling efficiency was measured using
Ellman’s test and MALDI-ToF MS. The molar extinction
coefficient at 280 nm was calculated by adding the calculated
molar extinction coefficient of protein variants with the one
measured for the phenanthroline or the terpyridine moiety.
The latter was determined in a 70% ethanol solution of a
known concentration of 1,10-phenanthroline and terpyridine,
giving a molar extinction coefficient of 22 4281 and 8000 M−1·
cm−1, respectively.
Mass Spectrometry Analysis. Protein solutions were
desalted on a Zeba Spin column (Thermo) against 10 mM
NH4HCO3 buffer pH 8 and then diluted in a sinapinic acid
matrix for MALDI-ToF MS analysis in linear mode by using a
MALDI-ToF/ToF UltrafleXtreme spectrometer (Bruker Dal-
tonics).
Metallation of the apo-Biohybrids. Aqueous Cu(NO3)2·
3H2O (1 μL, 10 mM) was added to 100 μL of 100 μM
solution of either A3_A3, (A3_A3′)F119C-Phen, (A3_A3′)-
F119C-Terpy, (A3_A3′)Y26C-Phen or (A3_A3′)Y26C-Terpy
in buffer A and gently yet thoroughly mixed by pipetting in
order to obtain a 1:1 copper(II)/protein ratio. The solutions
were kept on ice in a cold room overnight.
Analytical Size Exclusion Chromatography. Analytical
size exclusion chromatography was done essentially as
described7 with an ÄKTA Purifier (GE Healthcare) system
on a Superdex 75 10/300 GL column (flow rate 1 mL·min−1)
equilibrated with buffer A. Solutions containing sample
proteins were injected and elution profiles were recorded by
following the absorbance at 280 nm.
Molecular Modeling. The geometry of the Trojan horse
models (cofactor, substrate bound cofactor, and product
models) were optimized with Gaussian 09 (Gaussian 09,
revision D.01. Gaussian, Inc.: Wallingford, CT, 2010) using the
wave function B3LYP-D322 and the SMD continuum model
for water23 (see Supporting Information for further details).
The dimeric bio-assembly of the X-ray structure of the
A3_A3 bidomain protein (PDB ID 6FT5) was used to model
the different biohybrid variants (A3_A3′)F119C and
(A3_A3′)Y26C by mutating the relevant side chains. The
positions of the bidomain A3_A3′ protein were numbered
starting from residue number 3, as the first two residues of the
sequence were lacking in the crystal structure. The numbers of
the mutated positions were thus in accordance with those
described previously for the A3 homodimer.3 All the structural
handling performed at the beginning of the study was carried
out by means of UCSF Chimera embedded software.24
Covalent protein−ligand docking assays were performed
with the program GOLD (version 5.2)25 using the GoldScore
scoring function26 and considering the bond between the
cofactor and the sulfur of the mutated cysteine as the covalent
anchoring. An evaluation sphere of 20 Å radius centered on the
sulfur atom of the mutated cysteines was used for each
simulation. In all the calculations, the Trojan horses and the
linker were treated as flexible structures.
The solutions were analyzed by means of GaudiView GUI
extension for Chimera27 taking into account three main
criteria, the maximum value of the GoldScore Fitness (Fmax),
the position in the global energy ranking, and the population of
the solution clusters.
General Procedure for the Catalysis of Diels−Alder
Cyclization Reactions. All solutions were kept on ice and
reaction runs were performed in duplicate in 2 mL Eppendorf
conical tubes. In these tubes, the following were added
successively: 150 μL of the 100 μM solution of copper(II)-
biohybrid prepared previously (final concentration 30 μM), 5
μL of a stock solution of 100 mM azachalcone 4 (final
concentration 1 mM, 33 equiv), 5 μL of a 187 mM
diphenylsulfone solution used as an internal standard (final
concentration 1.87 mM) in acetonitrile, and finally 1.4 μL of
pure freshly distilled cyclopentadiene 5 (final concentration 34
mM, 1133 equiv) into buffer A for a final volume of 500 μL.
The tubes were then placed in the ThermoMixer comfort and
stirred at 500 rpm for 48 h at 4 °C. Ethyl acetate (3 × 500 μL)
was used for extracting the reaction mixture. After
centrifugation, organic layers were collected and dried over
MgSO4. HPLC analyses were then performed at 20 °C on an
Agilent Technologies 1260 Infinity apparatus equipped with a
Lux Cellulose-1 (250 × 4.6 mm, 5 μm) and n-hexane/
isopropanol (99/1) as the mobile phase at a 0.5 mL·min−1 flow
rate (DAD: 270 nm for 6 and diphenylsulfone, 300 nm for 4).
The peaks corresponding to the four stereoisomers were
identified by comparison with those of authentic samples:
retention times: 15.4 and 17.0 min (6 exo isomers), 18.7 and
24.6 min (6 endo isomers), 29.1 min (starting material, 4), and
61 min (internal standard, diphenylsulfone). The stereo-
isomers were assessed after circular dichroism measurements.7
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B.; Hermoso, J. A.; Palomo, J. M. Synthesis of a Heterogeneous
Artificial Metallolipase with Chimeric Catalytic Activity. Chem.
Commun. 2015, 51, 9324−9327.
(18) Reetz, M. T.; Jiao, N. Copper-Phthalocyanine Conjugates of
Serum Albumins as Enantioselective Catalysts in Diels-Alder
Reactions. Angew. Chem., Int. Ed. 2006, 45, 2416−2419.
(19) Osseili, H.; Sauer, D. F.; Beckerle, K.; Arlt, M.; Himiyama, T.;
Polen, T.; Onoda, A.; Schwaneberg, U.; Hayashi, T.; Okuda, J.
Artificial Diels-Alderase based on the transmembrane protein FhuA.
Beilstein J. Org. Chem. 2016, 12, 1314−1321.
(20) Eyer, P.; Worek, F.; Kiderlen, D.; Sinko, G.; Stuglin, A.;
Simeon-Rudolf, V.; Reiner, E. Molar Absorption Coefficients for the
Reduced Ellman Reagent: Reassessment. Anal. Biochem. 2003, 312,
224−227.
(21) Maayan, G.; Yoo, B.; Kirshenbaum, K. Heterocyclic Amines for
the Construction of Peptoid Oligomers Bearing Multi-Dentate
Ligands. Tetrahedron Lett. 2008, 49, 335−338.
(22) Grimme, S.; Antony, J.; Ehrlich, S.; Krieg, H. A Consistent and
Accurate Ab Initio Parametrization of Density Functional Dispersion
Correction (DFT-D) for the 94 Elements H-Pu. J. Chem. Phys. 2010,
132, 154104.
(23) Marenich, A. V.; Cramer, C. J.; Truhlar, D. G. Universal
Solvation Model Based on Solute Electron Density and on a
Continuum Model of the Solvent Defined by the Bulk Dielectric
Constant and Atomic Surface Tensions. J. Phys. Chem. B 2009, 113,
6378−6396.
(24) Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.;
Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera?A
Visualization System for Exploratory Research and Analysis. J.
Comput. Chem. 2004, 25, 1605−1612.
(25) Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R.
Development and Validation of a Genetic Algorithm for Flexible
Docking 1 1Edited by F. E. Cohen. J. Mol. Biol. 1997, 267, 727−748.
(26) Jones, G.; Willett, P.; Glen, R. C. Molecular Recognition of
Receptor Sites Using a Genetic Algorithm with a Description of
Desolvation. J. Mol. Biol. 1995, 245, 43−53.
(27) Rodríguez-Guerra Pedregal, J.; Sciortino, G.; Guasp, J.;
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